Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene.

Sun Z, Zhu Y, Wang Q, Ye L, Dai Y, Su S, Yu F, Ying T, Yang C, Jiang S, Lu L.

Emerg Microbes Infect. 2016 Jun 22;5:e65. doi: 10.1038/emi.2016.86.

2.

Using optical trap to measure the refractive index of a single animal virus in culture fluid with high precision.

Pang Y, Song H, Cheng W.

Biomed Opt Express. 2016 Apr 4;7(5):1672-89. doi: 10.1364/BOE.7.001672. eCollection 2016 May 1.

3.

Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.

DeSantis MC, Kim JH, Song H, Klasse PJ, Cheng W.

J Biol Chem. 2016 Jun 17;291(25):13088-97. doi: 10.1074/jbc.M116.729210. Epub 2016 Apr 25.

PMID:
27129237
4.

How Viruses Invade Cells.

Cohen FS.

Biophys J. 2016 Mar 8;110(5):1028-32. doi: 10.1016/j.bpj.2016.02.006. Review. No abstract available.

PMID:
26958878
5.

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.

Antanasijevic A, Kingsley C, Basu A, Bowlin TL, Rong L, Caffrey M.

J Biomol NMR. 2016 Mar;64(3):255-65. doi: 10.1007/s10858-016-0025-1. Epub 2016 Feb 26.

PMID:
26921030
6.

The Role of the Membrane in the Structure and Biophysical Robustness of the Dengue Virion Envelope.

Reddy T, Sansom MS.

Structure. 2016 Mar 1;24(3):375-82. doi: 10.1016/j.str.2015.12.011. Epub 2016 Jan 28.

7.

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection.

Zhao C, Ao Z, Yao X.

Vaccines (Basel). 2016 Jan 22;4(1). pii: E2. doi: 10.3390/vaccines4010002. Review.

8.

Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.

Wessler T, Chen A, McKinley SA, Cone R, Forest G, Lai SK.

ACS Infect Dis. 2016 Jan 8;2(1):82-92. Epub 2015 Oct 17.

PMID:
26771004
9.

Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion.

Garcia NK, Lee KK.

Viruses. 2016 Jan 11;8(1). pii: E15. doi: 10.3390/v8010015. Review.

10.

The role of Fc receptors in HIV prevention and therapy.

Boesch AW, Brown EP, Ackerman ME.

Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339. Review.

PMID:
26497529
11.

Morphology and ultrastructure of retrovirus particles.

Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM.

AIMS Biophys. 2015;2(3):343-369. Epub 2015 Aug 18.

12.

Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens.

Sattentau QJ.

Vaccines (Basel). 2013 Oct 28;1(4):497-512. doi: 10.3390/vaccines1040497. Review.

13.
14.
15.

Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Tarr AW, Khera T, Hueging K, Sheldon J, Steinmann E, Pietschmann T, Brown RJ.

Viruses. 2015 Jul 17;7(7):3995-4046. doi: 10.3390/v7072809. Review.

16.

Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.

Yang K, Lan J, Shepherd N, Hu N, Xing Y, Byrd D, Amet T, Jewell C, Gupta S, Kounga C, Gao J, Yu Q.

J Virol. 2015 Sep;89(18):9393-406. doi: 10.1128/JVI.01614-15. Epub 2015 Jul 1.

17.

Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.

Chen A, McKinley SA, Shi F, Wang S, Mucha PJ, Harit D, Forest MG, Lai SK.

PLoS One. 2015 Jul 1;10(7):e0131351. doi: 10.1371/journal.pone.0131351. eCollection 2015.

18.

Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.

Leaman DP, Lee JH, Ward AB, Zwick MB.

J Virol. 2015 Jul;89(13):6725-45. doi: 10.1128/JVI.03738-14. Epub 2015 Apr 15.

19.

Viral membrane fusion.

Harrison SC.

Virology. 2015 May;479-480:498-507. doi: 10.1016/j.virol.2015.03.043. Epub 2015 Apr 10. Review.

20.

Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.

Mengistu M, Ray K, Lewis GK, DeVico AL.

PLoS Pathog. 2015 Mar 25;11(3):e1004772. doi: 10.1371/journal.ppat.1004772. eCollection 2015 Mar. Erratum in: PLoS Pathog. 2015 Jun;11(6):e1004990.

Items per page

Supplemental Content

Write to the Help Desk